S100 proteins interact with the N-terminal domain of MDM2 (Q24336983)

https://api.crossref.org/works/10.1016/J.FEBSLET.2010.06.024

Binding of S100 proteins to RAGE: an update.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.FEBSLET.2010.06.024

Calcium-dependent and -independent interactions of the S100 protein family.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.FEBSLET.2010.06.024

The luminescence immunoassay S-100: a sensitive test to measure circulating S-100B: its prognostic value in malignant melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.FEBSLET.2010.06.024

Members of the S100 family bind p53 in two distinct ways

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.FEBSLET.2010.06.024

Proteins of the S100 family regulate the oligomerization of p53 tumor suppressor

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.FEBSLET.2010.06.024

Modulation of the oligomerization state of p53 by differential binding of proteins of the S100 family to p53 monomers and tetramers

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.FEBSLET.2010.06.024

Inhibition of p53 transcriptional activity by the S100B calcium-binding protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.FEBSLET.2010.06.024

The calcium-binding protein S100A2 interacts with p53 and modulates its transcriptional activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.FEBSLET.2010.06.024

S100A6 binds p53 and affects its activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.FEBSLET.2010.06.024

MDM2--master regulator of the p53 tumor suppressor protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.FEBSLET.2010.06.024

Molecular mechanism of the interaction between MDM2 and p53.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.FEBSLET.2010.06.024

The central region of HDM2 provides a second binding site for p53.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.FEBSLET.2010.06.024

Effects of common cancer mutations on stability and DNA binding of full-length p53 compared with isolated core domains

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.FEBSLET.2010.06.024

Cooperative regulation of p53 by modulation of ternary complex formation with CBP/p300 and HDM2

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.FEBSLET.2010.06.024

MDM2 and MDM4: p53 regulators as targets in anticancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.FEBSLET.2010.06.024

Recognition of the tumor suppressor protein p53 and other protein targets by the calcium-binding protein S100B

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.FEBSLET.2010.06.024

7 January 2021

A review of the S100 proteins in cancer

1 reference

https://api.crossref.org/works/10.1016/J.FEBSLET.2010.06.024

7 January 2021

Posttranslational modifications affect the interaction of S100 proteins with tumor suppressor p53

1 reference

https://api.crossref.org/works/10.1016/J.FEBSLET.2010.06.024

7 January 2021

Calcium and S100B regulation of p53-dependent cell growth arrest and apoptosis

1 reference

https://api.crossref.org/works/10.1016/J.FEBSLET.2010.06.024

7 January 2021

Concerted regulation of wild-type p53 nuclear accumulation and activation by S100B and calcium-dependent protein kinase C.

1 reference

https://api.crossref.org/works/10.1016/J.FEBSLET.2010.06.024

7 January 2021